• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 1X40 US; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 1X40 US; BONE CEMENT, ANTIBIOTIC Back to Search Results
Model Number 110034355
Device Problem Fire (1245)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/06/2021
Event Type  malfunction  
Manufacturer Narrative
This is a combination product (b)(4).The investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Event Description
It was reported, that during placement of cement on tibia, with the tibia subluxed and soft tissues protected, bovie cauterization (electrosurgical cauterization) was utilized in the medial parapatellar area.At this point, an assistant noticed at the center part of the cement, that a low flame was noted, was tamped, put out immediately glowing on surface of cement.The cement was removed.The wound was copiously irrigated once again.Witnessed no tissues compromised or flame adjacent to tissues.Cementing technique was performed.The implants were put in atraumatically.No adverse events have been reported as a result of the malfunction.
 
Event Description
It was reported, that during placement of cement on tibia, with the tibia subluxed and soft tissues protected, bovie cauterization (electrosurgical cauterization) was utilized in the medial parapatellar area.At this point, an assistant noticed at the center part of the cement, that a low flame was noted, was tamped, put out immediately glowing on surface of cement.The cement was removed.The wound was copiously irrigated once again.Witnessed no tissues compromised or flame adjacent to tissues.Cementing technique was performed.The implants were put in atraumatically.No adverse events have been reported as a result of the malfunction.
 
Manufacturer Narrative
This is a combination product (b)(4).This follow-up report is being submitted to relay additional information.The device manufacturing quality record indicate that the released product met all requirements to perform as intended.Complaint history identified no other similar event for the reported item and part/lot combinations.The root cause of the reported issue is attributed to user.It was reported the use of electrocautery devices in surgical sites near freshly implanted bone cement.Ifu requires to adequately ventilate the operating room to eliminate as much monomer vapor as possible.The liquid monomer is highly volatile and flammable.A summary of the investigation was sent to the complainant conveying proper surgical technique and use of the device.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFOBACIN BONE CEMENT R 1X40 US
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key13141116
MDR Text Key283077270
Report Number3006946279-2022-00002
Device Sequence Number1
Product Code MBB
UDI-Device Identifier00880304990197
UDI-Public00880304990197
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K171540
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/03/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2023
Device Model Number110034355
Device Catalogue Number110034355
Device Lot NumberZ50BAK2305
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/08/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/19/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-